Cannabis is an illegal narcotic. Cultivation, also
for medical purposes, is only possible with an exceptional authorisation
of the Swiss Federal Office of Public Health (BAG/FOPH).
Cannapharm cultivates its cannabis in close
cooperation with various Switzerland-based contractual partners, all
with authorisations of the BAG/FOPH.
Cannapharm holds an authorisation from the BAG/FOPH
for breeding and evaluation of varieties of cannabis. We cultivate an
increasing number of mother plants of selected varieties of cannabis,
kept in permanent vegetative growth with the support of artificial
For the manufacturing of products for medicinal use
or scientific research, genetically identical clones are cut from the
mother plants and brought to flowering in the field, in the greenhouse
or under artificial light.
All tasks relating to propagation, growth, harvesting and processing of our plants are conducted in accordance with the requirements of GAP (Good Agricultural Practice).
Cannapharm holds an authorisation from Swissmedic, the Swiss Agency for Therapeutic Products, for the manufacture and wholesale distribution of medicinal products.
All tasks relating to manufacture and analysis of our products are carried out with utmost care and in accordance with the requirements of GMP (Good Manufacturing Practice).